3 Undervalued Pharmaceuticals Stocks for Wednesday, June 17
Discover the top 3 undervalued Pharmaceuticals stocks for Wednesday, June 17 based on AAII’s Stock Grades.Jenna Brashear
| SECTOR | INDUSTRY |
| Health Care | Pharmaceuticals |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Jenna Brashear
Cynthia McLaughlin
Omar Beirat
Rosalio Madrigal
| Share Statistics | PBH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,366.2 | $569.9 | 56% |
|
| Shares Out (Mil) | 47.7 | 44.8 | 47% |
|
| Institutional Ownership | 98.8% | 84.6% | 82% |
|
| Float (Mil) | 46.7 | 45.1 | 46% |
|
| Beta | 0.35 | 0.67 | 20% |
|
| Avg Daily Volume (000s) | 483 | 294 | 58% |
|
| Price Change (52-week) |
(33.1%) | 65.2% | 23% |
|
| Growth | PBH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 2.9% | 6.7% | 27% |
|
| Net Income (5yr) | 2.9% | (2.0%) | 44% |
|
| EPS (5yr) | 3.8% | 14.9% | 36 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 10.8% | (14.9%) | 70% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 6 | 3 | 4 | |
| Current EPS | $0.872 | $4.607 | $4.983 | |
| Month Ago EPS | $0.870 | $4.607 | $5.070 | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 2 | 0 | 0 | |
| Three Months Ago EPS | $0.990 | $4.805 | $5.043 | |
| Year/Year Chg | (23.2%) | 17.8% | 32.2% | |
| Financials | PBH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,089 | $230 | 52% |
|
| Net Income (TTM) (Mil) | $190 | ($11) | 68% |
|
| EPS (TTM) | $3.927 | ($0.600) | 83% |
|
| Operating Cash Flow (TTM) (Mil) | $258 | ($6) | 62% |
|
| Net Cash Flow (TTM) (Mil) | ($34) | $4 | 22% |
|
| Long-Term Debt (Q1) (Mil) | $1,033 | $7 | 67% |
|
| Enterprise Value (Q1) (Mil) | $3,304 | $493 | 56% |
|
| Valuation | PBH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.25 | 2.89 | 32% |
|
| P/E | 12.8 | 20.6 | 27% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 3.4 | 1.1 | 80% |
|
| Ratios | PBH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 55.7% | 65.9% | 68% |
|
| Net Margin | 17.5% | (0.2%) | 76% |
|
| ROA | 5.5% | (25.5%) | 74% |
|
| ROE | 10.2% | (21.4%) | 58% |
|
| Liabilities to Assets | 46.0% | 35.5% | 37% |
|
| F-Score | 5 | 3 | 51% |
|
Prestige Consumer Healthcare Inc. did not pass any screens on 7/30/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors